1/13
08:20 am
ormp
Lifeward Enters Transformative Strategic Investment and Partnership Agreement with Oramed to Create a Diversified Biomedical Innovation Company [Yahoo! Finance]
Low
Report
Lifeward Enters Transformative Strategic Investment and Partnership Agreement with Oramed to Create a Diversified Biomedical Innovation Company [Yahoo! Finance]
1/13
07:58 am
ormp
Oramed and Lifeward Announce Strategic Transaction
Low
Report
Oramed and Lifeward Announce Strategic Transaction
1/7
08:55 am
ormp
Oramed Receives $18 Million Payment from Scilex Holdings, Bringing Current Returns to $118 Million; Board Approves Dividend Payments
Medium
Report
Oramed Receives $18 Million Payment from Scilex Holdings, Bringing Current Returns to $118 Million; Board Approves Dividend Payments
12/10
04:10 am
ormp
Oramed Pharmaceuticals (NASDAQ:ORMP) had its "hold (c)" rating reaffirmed by analysts at
Weiss Ratings.
Medium
Report
Oramed Pharmaceuticals (NASDAQ:ORMP) had its "hold (c)" rating reaffirmed by analysts at
Weiss Ratings.
11/17
09:05 am
ormp
Oramed Reports Fiscal Third Quarter 2025 Financial Results [Yahoo! Finance]
Low
Report
Oramed Reports Fiscal Third Quarter 2025 Financial Results [Yahoo! Finance]
11/17
08:56 am
ormp
Oramed Reports Fiscal Third Quarter 2025 Financial Results
Low
Report
Oramed Reports Fiscal Third Quarter 2025 Financial Results
11/17
08:50 am
ormp
ORAMED PHARMACEUTICALS INC. DECLARES DIVIDEND DISTRIBUTION OF COMMON STOCK PURCHASE RIGHTS
Low
Report
ORAMED PHARMACEUTICALS INC. DECLARES DIVIDEND DISTRIBUTION OF COMMON STOCK PURCHASE RIGHTS
10/23
08:11 pm
ormp
Oramed Releases Letter to Shareholders, Highlighting Developments in its Oral Insulin Program, Significant Investment Appreciation, and Upcoming Growth Initiatives [Yahoo! Finance]
Low
Report
Oramed Releases Letter to Shareholders, Highlighting Developments in its Oral Insulin Program, Significant Investment Appreciation, and Upcoming Growth Initiatives [Yahoo! Finance]